Technology market

Antibody Library Technology Market Report 2022: Growing Demand for Highly Targeted Therapies Drives Growth –

DUBLIN–(BUSINESS WIRE)–The “Antibody Library Technology Market Analysis, By Technology, By Application, By End User And By Region – Global Forecast to 2029” report has been added to from offer.

The Antibody Library Technology Market size is estimated at USD 145.71 Million in 2021 and is expected to witness a CAGR of 4.76% during the forecast period 2022-2029. Rising demand for highly targeted therapies to treat a variety of serious diseases like cancer and other diseases, increased incidence of chronic disorders are factors contributing to the growth of the market. However, the high price is expected to dampen growth.

By technology

Based on technology, the market is categorized into Ribosome Display, Mammalian Cell Surface Display, Phage Display, and Yeast Display. In 2021, phage display and yeast display accounted for the highest revenue share due to the fact that yeast surface display is an efficient technique to isolate and engineer antibodies to increase their affinity and their stability and that phage display is widely used because it is a versatile tool. in vitro selection technology used to find high affinity.

By request

Based on application, the market is categorized into drug discovery and development and research application. In the global market, the drug discovery and development segment accounted for the largest revenue share in 2021 due to the fact that it is used in several drug discovery and development trials for the treatment of numerous rare diseases , including cancer and HIV.

Per end user

Based on end-user, the market is segmented into academic and research institutes, biopharmaceutical companies, and contract research organization. In 2021, the biopharmaceutical companies segment accounted for the largest share of revenue due to the fact that they use antibody library technology for a variety of therapeutic treatments.

This comprehensive research report focuses on the global and regional market size and forecast of various segments including technology, application and end user from 2021 to 2029.

Segmentation: Antibody Library Technology Market Report 2021-2029 Technology (Revenue, USD Million)

  • Display of ribosomes

  • Mammalian cell surface display

  • Phage display

  • Display of yeast

Application (revenue, million USD)

  • Drug discovery and development

  • Search request

End User (Revenue, Million USD)

  • Academic and research institutes

  • Biopharmaceutical companies

  • Contract Research Organization

By Region (Revenue, USD Million)

North America


  • Germany

  • France

  • UK

  • Spain

  • Italy

  • The rest of Europe

Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of APAC

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Rest of LATAM

Middle East and Africa

  • South Africa

  • GCC

  • Rest of MEA

Main topics covered:

1. Research methodology

2. Introduction: Antibody Library Technology

3. Executive Summary

4. Market dynamics

5. Analysis of the market environment

6. COVID-19 Impact Analysis: Antibody Library Technology Market

7. Market Analysis by Technology

8. Market Analysis by Application

9. Market Analysis by End User

10. Regional Market Analysis

11. North America Antibody Library Technology Market

12. Europe Antibody Library Technology Market

13. Asia-Pacific Antibody Library Technology Market

14. Latin America Antibody Library Technology Market

15. MEA Antibody Library Technology Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion and Recommendations

Companies cited

  • Abcam plc. (UK)

  • Cell Signaling Technology (US)

  • Analytik Jena AG (Germany)

  • Becton

  • Dickinson and Company (USA)

  • Bio-Rad Laboratories (USA)

  • F. Hoffmann-La Roche (Switzerland)

  • Agilent Technologies (USA)

  • Perkin Elmer (USA)

  • GenScript (China)

  • BioLegend (USA)

  • Illumia Inc. (USA)

  • ImmonoPresice Antibodies (Canada)

  • Thermo Fisher Scientific Inc. (USA)

  • Fujirebio (Sweden)

  • Omega BioTek (USA)

  • Merck KGaA (Germany)

  • Danaher Corporation (USA)

  • Dovetail Genomics (USA)

  • Lonza (Switzerland)

  • Atlas Antibody (Sweden)

For more information on this report, visit